Publications 2023

Westhrin M, Blazevski J, Textor A, Abdollahi P, Gopalakrishnan RP, Ngo LT, Hofgaard PO, Heinzelbecker J, Bobic S, Fossum E, Spång HCL, Braathen R, Bogen B (2023)
Id-neoantigen vaccine induces therapeutic CD8⁺ T cells against multiple myeloma: H chain-loss escapees cause FLC MM
J Immunother Cancer, 11 (8)
DOI 10.1136/jitc-2023-006944, PubMed 37607769

Publications 2022

Abdollahi P, Vandsemb EN, Børset M (2022)
Phosphatases of regenerating liver are key regulators of metabolism in cancer cells - role of Serine/Glycine metabolism
Curr Opin Clin Nutr Metab Care, 25 (1), 50-55
DOI 10.1097/MCO.0000000000000797, PubMed 34725313

Børset M, Elsaadi S, Vandsemb EN, Hess ES, Steiro IJ, Cocera Fernandez M, Sponaas AM, Abdollahi P (2022)
Highly expressed genes in multiple myeloma cells - what can they tell us about the disease?
Eur J Haematol, 109 (1), 31-40
DOI 10.1111/ejh.13766, PubMed 35276027

Steiro I, Vandsemb EN, Elsaadi S, Misund K, Sponaas AM, Børset M, Abdollahi P, Slørdahl TS (2022)
The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
Oncotarget, 13, 1175-1186
DOI 10.18632/oncotarget.28300, PubMed 36268559

Publications 2021

Abdollahi P, Vandsemb EN, Elsaadi S, Røst LM, Yang R, Hjort MA, Andreassen T, Misund K, Slørdahl TS, Rø TB, Sponaas AM, Moestue S, Bruheim P, Børset M (2021)
Phosphatase of regenerating liver-3 regulates cancer cell metabolism in multiple myeloma
FASEB J, 35 (3), e21344
DOI 10.1096/fj.202001920RR, PubMed 33566385

Elsaadi S, Steiro I, Abdollahi P, Vandsemb EN, Yang R, Slørdahl TS, Rø TB, Menu E, Sponaas AM, Børset M (2021)
Targeting phosphoglycerate dehydrogenase in multiple myeloma
Exp Hematol Oncol, 10 (1), 3
DOI 10.1186/s40164-020-00196-w, PubMed 33397437

Vandsemb EN, Rye MB, Steiro IJ, Elsaadi S, Rø TB, Slørdahl TS, Sponaas AM, Børset M, Abdollahi P (2021)
PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1/2
FEBS J, 288 (23), 6700-6715
DOI 10.1111/febs.16058, PubMed 34092011

Publications 2020

Abdollahi P, Köhn M, Børset M (2020)
Protein tyrosine phosphatases in multiple myeloma
Cancer Lett, 501, 105-113
DOI 10.1016/j.canlet.2020.11.042, PubMed 33290866

Yang R, Elsaadi S, Misund K, Abdollahi P, Vandsemb EN, Moen SH, Kusnierczyk A, Slupphaug G, Standal T, Waage A, Slørdahl TS, Rø TB, Rustad E, Sundan A, Hay C, Cooper Z, Schuller AG, Woessner R, Borodovsky A, Menu E, Børset M, Sponaas AM (2020)
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
J Immunother Cancer, 8 (1)
DOI 10.1136/jitc-2020-000610, PubMed 32409420

Publications 2018

Hjort MA, Hov H, Abdollahi P, Vandsemb EN, Fagerli UM, Lund B, Slørdahl TS, Børset M, Rø TB (2018)
Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration
Exp Hematol Oncol, 7, 8
DOI 10.1186/s40164-018-0100-2, PubMed 29651360

Publications 2017

Hjort MA, Abdollahi P, Vandsemb EN, Fenstad MH, Lund B, Slørdahl TS, Børset M, Rø TB (2017)
Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance
Oncotarget, 9 (3), 3549-3561
DOI 10.18632/oncotarget.23186, PubMed 29423065

Publications 2016

Abdollahi P, Vandsemb EN, Hjort MA, Misund K, Holien T, Sponaas AM, Rø TB, Slørdahl TS, Børset M (2016)
Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3
Mol Cancer Res, 15 (1), 69-77
DOI 10.1158/1541-7786.MCR-16-0212, PubMed 27698077

Slørdahl TS, Abdollahi P, Vandsemb EN, Rampa C, Misund K, Baranowska KA, Westhrin M, Waage A, Rø TB, Børset M (2016)
The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells
Oncotarget, 7 (19), 27295-306
DOI 10.18632/oncotarget.8422, PubMed 27036022

Vandsemb EN, Bertilsson H, Abdollahi P, Størkersen Ø, Våtsveen TK, Rye MB, Rø TB, Børset M, Slørdahl TS (2016)
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration
J Transl Med, 14, 71
DOI 10.1186/s12967-016-0830-z, PubMed 26975394

Publications 2015

Abdollahi P, Ebrahimi M, Motamed N, Samani FS (2015)
Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468
Anticancer Drugs, 26 (5), 487-97
DOI 10.1097/CAD.0000000000000205, PubMed 25603020